Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer

被引:53
作者
Nakama, H [1 ]
Zhang, B [1 ]
Zhang, X [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Publ Hlth, Matsumoto, Nagano 3908621, Japan
关键词
colonoscopy; cost-effectiveness; cut-off point; fecal haemoglobin; immunochemical occult blood test;
D O I
10.1016/S0959-8049(00)00387-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study was carried out to assess, from the aspects of cost-effectiveness and diagnostic validity. the optimum cut-off point for immunochemical occult blood testing using a 2-day method as a means of screening for colorectal cancer. Four thousand, two hundred and sixty asymptomatic individuals were subjects of this study. They gave samples for all immunochemical fecal occult blood test, and colonoscopy was carried out during a medical check-up. For evaluation of the optimum cut-off point, three cut-off levels of fecal haemoglobin, 50, 150 and 300 ng/ml, were used. A total of 27 patients with colorectal cancer were diagnosed. The average costs to detect one patient with colorectal cancer and the sensitivity and specificity of these three cut-off points of fecal haemoglobin were evaluated. The average costs for the detection of one cancer case were calculated as $2870.45 for cut-off level of 50 ng/ml, $2492.98 for that of 150 ng/ml and $3329.09 for that of 300 ng/ml. respectively. The sensitivity and specificity were calculated as 89 and 94% for the 50 ng/ml cut-off level, 81% and 96% for the 150 ng/ml cut-off level and 56 and 97% for the 300 ng/ml cut-off level, respectively, indicating a significant difference in the sensitivity between the 50 and 300 ng/ml levels (P < 0.05), as well as between the 150 and 300 ng/ml levels (P < 0.05), and a significant difference in the specificity between the 50 and 300 ng/ml levels (P < 0.05). However, no significant difference was observed in the specificity between the 50 and 150 ng/ml levels. The findings show that 150 ng/ml of fecal haemoglobin is the optimal cut-off point when carrying out the OC-Hemodia test as a means of screening for colorectal cancer. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:398 / 401
页数:4
相关论文
共 18 条
[1]   A comparison of fecal occult-blood tests for colorectal-cancer screening [J].
Allison, JE ;
Tekawa, IS ;
Ransom, LJ ;
Adrain, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :155-159
[2]  
Fattah ASMA, 1998, HEPATO-GASTROENTEROL, V45, P712
[3]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[4]   CLINICOPATHOLOGICAL STUDIES OF IMMUNOLOGICAL FECAL OCCULT BLOOD-TEST FOR COLORECTAL-CANCER [J].
IIDA, Y ;
MUNEMOTO, Y ;
MIURA, S ;
KASAHARA, Y ;
SAITO, H ;
MITSUI, T ;
ASADA, Y ;
FUKUOKA, K ;
TOYA, D ;
TANAKA, N ;
KIMURA, A ;
FUJISAWA, M .
JOURNAL OF GASTROENTEROLOGY, 1995, 30 (02) :195-200
[5]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471
[6]   COST-EFFECTIVENESS MODEL FOR COLON-CANCER SCREENING [J].
LIEBERMAN, DA .
GASTROENTEROLOGY, 1995, 109 (06) :1781-1790
[7]   REDUCING MORTALITY FROM COLORECTAL-CANCER BY SCREENING FOR FECAL OCCULT BLOOD [J].
MANDEL, JS ;
BOND, JH ;
CHURCH, TR ;
SNOVER, DC ;
BRADLEY, GM ;
SCHUMAN, LM ;
EDERER, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (19) :1365-1371
[8]  
Nakama H, 1998, HEPATO-GASTROENTEROL, V45, P752
[9]   A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer [J].
Nakama, H ;
Zhang, B ;
Fattah, ASMA .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) :647-650
[10]  
NAKAMA H, 1994, CLIN INVESTIGATOR, V72, P117